Study Finds AeroFarms® Micro Broccoli Has Up to 35x More Nutrients Than Broccoli Florets

Study Finds AeroFarms® Micro Broccoli Has Up to 35x More Nutrients Than Broccoli Florets

AeroFarms, a global pioneer in indoor vertical farming and the leading supplier of microgreens to the U.S. retail market, has announced the results of an independent third-party study validating the exceptional nutritional value of its Micro Broccoli. The findings demonstrate…

Read MoreStudy Finds AeroFarms® Micro Broccoli Has Up to 35x More Nutrients Than Broccoli Florets
Arcitecta and Partners Unite for Inaugural DATAKAMER 2025 Event

Arcitecta and Partners Unite for Inaugural DATAKAMER 2025 Event

Arcitecta, a pioneer in innovative data management software, recently joined leading research institutions and technology partners—including Spectra Logic, Wasabi, Cerabyte, and IQM—at the inaugural DATAKAMER 2025 event. Hosted by the Dana-Farber Cancer Institute in Boston, Massachusetts, this exclusive, one-day forum…

Read MoreArcitecta and Partners Unite for Inaugural DATAKAMER 2025 Event
Scanogen Granted FDA Breakthrough Device Designation

Scanogen Granted FDA Breakthrough Device Designation for Rapid Bloodstream Infection Test

Scanogen Inc., a molecular diagnostics company at the forefront of next-generation infectious disease detection, announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation for its rapid assay designed to identify bloodstream infection pathogens directly from…

Read MoreScanogen Granted FDA Breakthrough Device Designation for Rapid Bloodstream Infection Test
ClearB Therapeutics Reports Sentinel Safety Outcome

ClearB Therapeutics Reports Sentinel Safety Outcome, Expands Phase 1b CLB-4000 Study in Chronic Hepatitis B

ClearB Therapeutics, Inc., a clinical-stage biotechnology company dedicated to developing therapies aimed at achieving functional cure in patients with chronic hepatitis B (CHB) infection, announced that the sentinel subject safety review in their ongoing Phase 1b study of CLB-4000 supports…

Read MoreClearB Therapeutics Reports Sentinel Safety Outcome, Expands Phase 1b CLB-4000 Study in Chronic Hepatitis B
Svante Celebrates Nobel Prize Win Highlighting MOF Technology’s Role in Carbon Capture

Svante Celebrates Nobel Prize Win Highlighting MOF Technology’s Role in Carbon Capture

Svante, a global leader in solid sorbent-based carbon capture and removal filter technology, celebrated the announcement of the 2025 Nobel Prize in Chemistry, awarded to scientists Susumu Kitagawa, Richard Robson, and Omar Yaghi for their pioneering work in the metal-organic…

Read MoreSvante Celebrates Nobel Prize Win Highlighting MOF Technology’s Role in Carbon Capture
Flatiron Health Advances Real-World Evidence with Predictive Insights and Scientific Innovation

Flatiron Health Advances Real-World Evidence with Predictive Insights and Scientific Innovation

Flatiron Health, a global leader in real-world oncology data and evidence generation, today announced a suite of groundbreaking scientific innovations that promise to redefine how the healthcare industry understands, interprets, and predicts real-world outcomes in cancer. With the launch of…

Read MoreFlatiron Health Advances Real-World Evidence with Predictive Insights and Scientific Innovation
Libra Therapeutics Names Martin Gill, Ph.D., as Chief Scientific Officer

Libra Therapeutics Names Martin Gill, Ph.D., as Chief Scientific Officer

Libra Therapeutics, Inc., a private biotechnology company pioneering novel disease-modifying therapeutics designed to restore cellular homeostasis and slow the progression of neurodegenerative diseases, today announced the promotion of Martin (Marty) Gill, Ph.D., to Chief Scientific Officer (CSO). Dr. Gill, who…

Read MoreLibra Therapeutics Names Martin Gill, Ph.D., as Chief Scientific Officer